Heart Test Laboratories I...
(HSCS)
undefined
undefined%
At close: undefined
3.77
0.00%
After-hours Dec 13, 2024, 03:27 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 |
| Cash & Equivalents | 5.81M | 1.66M | 918.26K | 723.48K | 496.85K |
| Short-Term Investments | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | - |
| Other Long-Term Assets | - | - | - | -289.33K | -418.05K |
| Receivables | - | - | 2.32K | - | - |
| Inventory | 629.18K | 676.36K | 674.14K | 750.77K | 857.01K |
| Other Current Assets | 917.07K | 359.75K | 89.76K | 163.79K | 183.95K |
| Total Current Assets | 7.35M | 2.70M | 1.93M | 1.64M | 1.54M |
| Property-Plant & Equipment | 559.97K | 590.65K | 158.57K | 289.33K | 418.05K |
| Goodwill & Intangibles | 1.59M | - | - | - | - |
| Total Long-Term Assets | 2.15M | 590.65K | 158.57K | 289.33K | 418.05K |
| Total Assets | 9.50M | 3.29M | 2.09M | 1.93M | 1.96M |
| Account Payables | 448.18K | 631.37K | 694.75K | 335.78K | 358.79K |
| Deferred Revenue | - | 623.39K | - | 421.16K | 337.59K |
| Short-Term Debt | 602.29K | 529.53K | 1.72M | 487.83K | 444.11K |
| Other Current Liabilities | 701.29K | 671.99K | 1.05M | 422.38K | 338.81K |
| Total Current Liabilities | 1.75M | 1.83M | 3.47M | 1.25M | 1.14M |
| Long-Term Debt | 434.05K | 1.04M | 4.44M | 2.59M | 498.60K |
| Other Long-Term Liabilities | - | 187.45K | 232.87K | - | - |
| Total Long-Term Liabilities | 434.05K | 1.22M | 4.67M | 2.59M | 498.60K |
| Total Liabilities | 2.19M | 3.06M | 8.15M | 3.84M | 1.64M |
| Total Debt | 1.04M | 1.57M | 6.16M | 3.08M | 942.71K |
| Common Stock | 677.00 | 10.12K | 3.32K | 3.31K | 3.31K |
| Retained Earnings | -67.36M | -60.76M | -54.40M | -49.57M | -47.12M |
| Comprehensive Income | - | -381.00K | -0.00 | - | - |
| Shareholders Equity | 7.32M | 230.56K | -6.06M | -1.91M | 315.55K |
| Total Investments | - | - | - | - | - |